Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study

Insights into the Functional Anatomy Behind the PREEMPT Injection Paradigm: Guidance on Achieving Optimal Outcomes

(2017) Andrew M. Blumenfeld et al.   HEADACHE

OnabotulinumtoxinA injections in chronic migraine, targeted to sites of pericranial myofascial pain: an observational, open label, real-life cohort study

(2017) Danièle Ranoux et al.   JOURNAL OF HEADACHE AND PAIN

Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study

(2016) David W. Dodick et al.   HEADACHE

Impact of Migraine on the Family: Perspectives of People With Migraine and Their Spouse/Domestic Partner in the CaMEO Study

(2016) Dawn C. Buse et al.   MAYO CLINIC PROCEEDINGS

Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine

(2015) Andrew M. Blumenfeld et al.   BMC Neurology

Acute Treatment Optimization in Episodic and Chronic Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study

(2015) Daniel Serrano et al.   HEADACHE

A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience

(2015) Andrea Negro et al.   JOURNAL OF HEADACHE AND PAIN

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins

(2015) Sara Schaefer et al.   Toxins

Acupoint Injection of Onabotulinumtoxin A for Migraines

(2015) Min Hou et al.   Toxins

OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study

(2015) Andrea Negro et al.   SpringerPlus

Validation of the Headache Impact Test (HIT-6) in patients with chronic migraine

(2014) Regina Rendas-Baum et al.   Health and Quality of Life Outcomes

OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program

(2013) S. K. Aurora et al.   ACTA NEUROLOGICA SCANDINAVICA

The International Classification of Headache Disorders, 3rd edition (beta version)

(2013)   CEPHALALGIA

Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study

(2012) Dawn C. Buse et al.   HEADACHE

Comorbidity profiles of chronic migraine sufferers in a national database in Taiwan

(2012) Yong-Chen Chen et al.   JOURNAL OF HEADACHE AND PAIN

Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS)

(2012) L. M. Bloudek et al.   JOURNAL OF HEADACHE AND PAIN

Headache Impact of Chronic and Episodic Migraine: Results From the American Migraine Prevalence and Prevention Study

(2011) Dawn Buse et al.   HEADACHE

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56-Week PREEMPT Clinical Program

(2011) Sheena K. Aurora et al.   HEADACHE

OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine

(2011) R. B. Lipton et al.   NEUROLOGY

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

(2010) SK Aurora et al.   CEPHALALGIA

Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)

(2010) AM Blumenfeld et al.   CEPHALALGIA

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

(2010) HC Diener et al.   CEPHALALGIA

Chronic Migraine: Epidemiology and Disease Burden

(2010) Aubrey N. Manack et al.   Current Pain and Headache Reports

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

(2010) David W. Dodick et al.   HEADACHE

Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers

(2010) D C Buse et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Global prevalence of chronic migraine: A systematic review

(2009) JL Natoli et al.   CEPHALALGIA

Guidelines for Controlled Trials of Prophylactic Treatment of Chronic Migraine in Adults

(2008) S Silberstein et al.   CEPHALALGIA

Chronic migraine in the population: Burden, diagnosis, and satisfaction with treatment

(2008) M. E. Bigal et al.   NEUROLOGY